Exhibit 99.1

                                                             Investor Inquiries
                                                             Gregory C. Thompson
                                                             440-329-6111


INVACARE CORPORATION PRICES SENIOR NOTES

ELYRIA, Ohio - (February 7, 2007) - Invacare Corporation (NYSE: IVC) ("Invacare"
or the "Company")  announced today the pricing of $175 million  principal amount
of its  Senior  Notes  due  2015 to be sold to  qualified  institutional  buyers
pursuant  to Rule 144A and to  non-U.S.  persons  outside  the United  States in
reliance on  Regulation  S under the  Securities  Act of 1933,  as amended  (the
"Securities Act"). The notes will be unsecured senior obligations of the Company
guaranteed by substantially all of the Company's domestic subsidiaries, and will
pay interest at 9 3/4% per annum on each  February 15 and August 15.  Subject to
customary conditions, the offering is expected to close on February 12, 2007.

The Company is negotiating a new financing program that is expected to result in
total capacity of approximately $700 million and is expected to include a senior
secured  revolving  credit facility and term loans, in addition to the notes and
$125 million principal amount of the Company's 4.125%  convertible  subordinated
debentures due 2027,  which priced on February 5, 2007.  The Company  intends to
use the net proceeds  from the sale of the notes,  together  with  proceeds from
these other financings that the Company is currently  negotiating,  to refinance
substantially  all of  its  existing  indebtedness  and  pay  related  fees  and
expenses.

The notes have not been  registered  under the  Securities Act or the securities
laws of any other  jurisdiction  and may not be  offered  or sold in the  United
States  absent  registration  under,  or  an  applicable   exemption  from,  the
registration  requirements of the Securities Act and applicable state securities
laws.

This press release shall not constitute an offer to sell or the  solicitation of
offers to buy any security and shall not  constitute an offer,  solicitation  or
sale of any security in any jurisdiction in which such offer,  solicitation,  or
sale would be unlawful.

Invacare  Corporation (NYSE: IVC),  headquartered in Elyria, Ohio, is the global
leader in the manufacture and distribution of innovative home and long-term care
medical  products that promote recovery and active  lifestyles.  The Company has
6,000  associates and markets its products in 80 countries around the world. For
more information about the Company and its products, visit Invacare's website at
www.invacare.com.

This press release contains forward-looking statements within the meaning of the
"Safe Harbor"  provisions  of the Private  Securities  Litigation  Reform Act of
1995. Terms such as "will," "should," "plan,"  "intend,"  "expect,"  "continue,"
"forecast", "believe," "anticipate" and "seek," as well as similar comments, are
forward-looking  in nature.  Actual results and events may differ  significantly
from those expressed or anticipated as a result of risks and uncertainties which
include,  but are not limited to, the  following:  possible  adverse  effects of
being substantially leveraged,  which could impact our ability to raise capital,
limit our ability to react to changes in the  economy or our  industry or expose
us to interest rate risks;  changes in government  and other  third-party  payor
reimbursement  levels and practices;  consolidation of health care customers and
our competitors; ineffective cost reduction and restructuring efforts; inability
to design, manufacture, distribute and achieve market acceptance of new products
with higher functionality and lower costs;  extensive  government  regulation of
our products;  lower cost imports;  increased  freight costs;  failure to comply
with regulatory requirements or receive regulatory clearance or approval for our
products  or  operations  in the  United  States or  abroad;  potential  product
recalls;  uncollectible accounts receivable;  difficulties in implementing a new
Enterprise Resource Planning system; legal actions or regulatory proceedings and
governmental  investigations;  product liability claims;  inadequate  patents or
other  intellectual  property  protection;   incorrect  assumptions   concerning
demographic  trends that impact the market for our  products;  provisions in our
bank credit  agreements  or other debt  instruments  that may prevent or delay a
change in control; the loss of the services of our key management and personnel;
decreased  availability  or increased  costs of raw materials could increase our
costs of producing  our  products;  inability to acquire  strategic  acquisition
candidates because of limited financing alternatives; risks inherent in managing
and operating businesses in many different foreign jurisdictions;  exchange rate
fluctuations,  as well as the risks  described  from time to time in  Invacare's
reports as filed with the  Securities  and  Exchange  Commission.  Except to the
extent  required  by law,  we do not  undertake  and  specifically  decline  any
obligation  to review or update any  forward-looking  statements  or to publicly
announce  the  results of any  revisions  to any of such  statements  to reflect
future events or developments or otherwise.